Navigation Links
Tengion Presents New Scientific Data in Presentations at TERMIS North America Annual Meeting
Date:12/13/2011

EAST NORRITON, Pa., Dec. 13, 2011 /PRNewswire/ -- Tengion, Inc. (NASDAQ: TNGN), a leader in regenerative medicine, today announced that new data from the Company's Neo-Urinary Conduit™ (NUC) and Neo-Kidney Augment™ (NUC) programs are featured in several presentations at the TERMIS North America Annual Conference being held December 11-14, in Houston, TX. 

The NUC program is further supported by various cellular and molecular studies demonstrating the genetic stability of the autologous smooth muscle cells used in the Neo-Urinary Conduit. Supporting the utility of the technology platform are additional experiments showing the suitability of using adipose-derived smooth muscle cells from bladder cancer patients who have undergone prior cancer treatment. In support of advancing the NKA program toward clinical studies, Tengion has previous demonstrated increased survival in an obese, diabetic rat model of chronic kidney disease. A new analysis using multiple species, including canines, demonstrated that NKA had broad regenerative outcomes in multiple kidney tissue compartments. Renal filtration, tubular and urine concentrating effects were all shown to be improved and constitute significant predictors for survival. To support clinical translation, prototype formulations which combined selected regenerative renal cells with various gelatin-based hydrogels were well-tolerated and elicited neo-kidney tissue regeneration. 

"These presentations highlight the work of Tengion scientists to translate regenerative medicine science into product candidates for patients," said Tim Bertram, DVM, Ph.D., President, Research and Development and Chief Scientific Officer of Tengion. "In our two lead programs, we continue to build the evidence for the specific cells and biomaterials used in our product candidates and their potential to address impo
'/>"/>

SOURCE Tengion, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Tengion to Present at UBS Global Life Sciences Conference
2. Tengion to Present at Rodman & Renshaw 13th Annual Healthcare Conference
3. Tengion Provides Business Update and Reports Second Quarter 2011 Financial Results
4. Tengion Announces Leadership Transition
5. Tengion Provides Business Update and Reports First Quarter 2011 Financial Results
6. Tengion to Host Conference Call to Provide a Business Update and Report First Quarter 2011 Financial Results on May 12, 2011
7. Tengion Announces Addition of Two Renal Experts to Research & Development Advisors Panel
8. Tengion To Host Conference Call To Provide a Business Update and Report Fourth Quarter 2010 Financial Results on March 25, 2011
9. Tengion Announces Pricing of $31.4 Million Private Placement
10. Tengion Addresses Recent Trading Activity in its Common Stock
11. Tengion to Present at the 13th Annual BIO CEO & Investor Conference and the Leerink Swann Hot Topics in Therapeutics Roundtable Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014 TaiGen Biotechnology Company, ... exclusive agreement with R-Pharm, a leading Russian pharmaceutical company, ... the Russian Federation , ... Independent States (CIS). Nemonoxacin is a novel antibiotic for the ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 Carahsoft and ... Thursday, January 23, 2014 at 2pm EST (11am PST), ... The topic focuses on how technology can turn raw, ... decisions for government agencies. The online webinar will last ...
(Date:1/14/2014)... leading provider of strategic communications services to corporations and organizations preparing ... the United States and Europe , ... returning to the firm,s Washington, D.C. office. ... two years of service as Associate Commissioner for the Office of ...
(Date:1/14/2014)... New York, NY (PRWEB) January 14, 2014 ... coverage of Alliqua, Inc. (OTCQB: ALQA). Alliqua is an ... products to serve the wound care market. , Free ... Alliqua was restructured with a seasoned management team and ...
Breaking Biology Technology:TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4Webcast - Natural Language Processing: Converting Raw Data into Actionable Knowledge – Hosted by Carahsoft and CDS Federal Services 2Former FDA Associate Commissioner Returns To 3D Communications 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3
... not your parents' generation of corporate leaders. , ,A ... cross the lips of gray-haired, gray-suited corporate executives. Today, ... Wisconsin doesn't yet have it. , ,At the Olympia ... academic and arts groups met to brainstorm strategies for ...
... Wis. - The 53 Wisconsin companies that won ... Innovation Research (SBIR) and Small Business Technology Transfer (STTR) ... at an upcoming banquet in Madison. , ,The awards ... transfer workshop. The workshop will focus on SBIR/STTR funding ...
... 30 years ago, then-Gov. Pat Lucey and the Wisconsin ... property taxes. It was a bipartisan decision that has ... times and foreign competition threatened. , ,Today, Wisconsin policymakers ... a competitive toehold by reducing state taxes that discourage ...
Cached Biology Technology:Tech leaders call for more creativity 2Modernizing the tax code can make Wisconsin tech businesses more competitive 2Modernizing the tax code can make Wisconsin tech businesses more competitive 3
(Date:4/24/2014)... turtle in North America, weighing in at up to ... from Florida and the University of Vermont have discovered ... , Examining museum specimens and wild turtles, the scientists ... Once heavily hunted for turtle meat alligator snapper ... the 1960s the riverine populations have been deeply ...
(Date:4/23/2014)... and other chronic inflammatory disorders among people of lower ... reduced exposure to the microbes that thrive in rural ... article, published in the journal Clinical & Experimental ... who have less access to green spaces may be ... by immune system dysfunction. , When our immune systems ...
(Date:4/23/2014)... in their mid-thirties and forties, face a devastating ... two decades. "Mutant" protein clusters, long blamed for ... the primary focus of therapies in development by ... Prof. Gerardo Lederkremer and Dr. Julia Leitman of ... Immunology, in collaboration with Prof. Ulrich Hartl of ...
Breaking Biology News(10 mins):Two new US turtle species described 2Two new US turtle species described 3Rural microbes could boost city dwellers' health 2Rural microbes could boost city dwellers' health 3On the defensive 2On the defensive 3
... some have argued, can be reversed with a large-scale ... liquefied sulfur dioxide in the stratosphere or building tens ... to filter out carbon dioxide. ... of Atmospheric and Oceanic Sciences and a member and ...
... biological tit for tat may hold clues to improving ... type 1 diabetes, according to a Medical College of ... attacks insulin-producing cells causing high blood glucose levels that ... an immunologist in the MCG Center for Biotechnology and ...
... Ind. - Purdue University researchers found a mechanism that ... how to keep that switch turned on may be ... Nicholas Carpita, a professor of botany and plant pathology, ... in plant development by shutting off genes involved in ...
Cached Biology News:No quick or easy technological fix for climate change, researchers say 2No quick or easy technological fix for climate change, researchers say 3No quick or easy technological fix for climate change, researchers say 4High blood sugar's impact on immune system holds clues to improving islet cell transplants 2High blood sugar's impact on immune system holds clues to improving islet cell transplants 3Researchers find nature's shut-off switch for cellulose production 2
Porcine Serum Available Anticoagulants: N-02: Citrate N-04: Heparin (Na) N-06: K2EDTA N-08: Potassium Oxalate N-10: EDTA (Na) N-03: Alsevers N-05: ACD N-07: CPD N-09: K3EDTA N-11...
Recombinant Viral CCI/Fc Chimera, CF...
... • Guinea Pig serum is collected from fasted ... N-02: Citrate N-04: Heparin (Na) ... Oxalate N-10: EDTA (Na) N-03: ... CPD N-09: K3EDTA N-11: ...
GENOMIPHI V2 DNA AMP KIT 25RXN, 1 EA. Category: Genomics DNA Amplification....
Biology Products: